BeOne Medicines stock price forecast: $282.43 support as ONC drops 1.53%
BeOne Medicines (ONC) stock is trading at $285.55, down 1.53% on the day. The stock remains above its near-term moving averages but has not reclaimed its longer-term trend, reflecting mixed momentum signals.
Highlights
- ONC/USD displays short- and medium-term bullish momentum, but faces persistent long-term bearish pressure below key resistance.
- Technical indicators present mixed signals, with momentum strong, oscillators neutral to oversold, and intraday price closing mid-range.
- Expected range for the next 2–3 days is $277.16 to $293.94, with high probability of an upside move unless support fails.
Intraday buyer strength as shorter-term indicators diverge
ONC remains above the SMA-20 and SMA-50 on the hourly chart, but continues to trade below the longer-term SMA-200 at $316.66. Immediate support is seen at the Ichimoku Kijun level of $282.43. The Moving Average Convergence Divergence (MACD) shows a Strong Buy signal, and the Average Directional Index (ADX) also indicates a Buy, while oscillator readings are mixed: the Relative Strength Index (RSI) is at 55.71 (Buy), the Stochastic RSI suggests oversold conditions, and the Commodity Channel Index (CCI) is neutral. Bull/Bear Power points to strong buyer dominance intraday, the Awesome Oscillator remains neutral, and the price closed the session mid-range after a gap down, suggesting moderate volatility and lingering divergence among shorter-term indicators.
Upside favored with volatility in narrow short-term range
In the short term, the expected price range for ONC over the next 2 to 3 trading days is $277.16 to $293.94. The probability of an upward move is classified as very high, with only a very low chance of further downside. The baseline scenario projects ONC fluctuating within this band. A sustained break above $293.94 could trigger renewed upside momentum, while a move below $277.16 would open the door to additional weakness.